If you have a question, who do you ask
"Technically, a patient is a candidate for semaglutide for weight loss purposes if their body mass index is 27 with weight-related comorbidities (like high blood pressure, high cholesterol, or diabetes) or 30+ with or without comorbidities," explains Dr
This is consistent with patient reports, which are generally more positive about mental health benefits for Zepbound (tirzepatide) than for Wegovy (semaglutide)
The FDA shortage exemption that broadly covered compounding from 20222024 has narrowed since semaglutide was removed from the shortage list
Lean mass loss: the silent saboteur This one matters more than most people realize
Please support CSPI today, and consider contributing monthly